학술논문
Personalised randomised controlled trial designs—a new paradigm to define optimal treatments for carbapenem-resistant infections
Document Type
Review Article
Author
Source
In The Lancet Infectious Diseases June 2021 21(6):e175-e181
Subject
Language
ISSN
1473-3099